載入...
Real-World Early Treatment with Room Temperature–Stable Recombinant Factor VIIa in Hemophilia A/B and Inhibitors: SMART-7™ Post Hoc Analyses
Treating hemophilia A or B patients with inhibitors is particularly challenging, as they do not respond to replacement therapy with factor VIII or factor IX concentrates. A room temperature–stable formulation of recombinant activated factor VII (rFVIIa; NovoSeven®), which provides improved convenien...
Na minha lista:
Main Authors: | , , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
Georg Thieme Verlag KG
2017-07-01
|
叢編: | TH Open |
主題: | |
在線閱讀: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0037-1608943 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|